person · Reporting owner

Waldman Lawrence

Disclosed activity across 4 companies

Tapewire entity: 33516
SEC CIK: 0001516592

Reported relationships

Latest disclosed role at each company.

Company	Last reported as	Report date	Published
Apyx Medical CorpAPYX · Entity 6609	Director	June 30, 2026	July 02, 2026
COMTECH TELECOMMUNICATIONS CORP /DE/CMTL · Entity 7226	Director	March 24, 2026	March 26, 2026
CVD EQUIPMENT CORPCVV · Entity 7247	Director	August 08, 2025	August 12, 2025

Disclosed balances

About these balances

Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.

Apyx Medical Corp

Report date June 30, 2026 · Filed July 02, 2026

Security / award	Ownership account	Disclosed shares / units	Disclosure context
Common StockSEC Table I · non-derivative	IndirectBy SLAT	12,314	Last balance in matching sequence After 2026-06-30 transaction · row 2 Source-order balances reconcile. Account continuity and personal attribution are not independently verified. 2 source rows Row 1 · 2026-06-30 · Exercise / conversion · Acquired 12,000 · Balance 17,338 F1: Held by a Spousal Lifetime Access Trust (the "SLAT"). The Reporting Person's spouse and children are trustees of the SLAT. The Reporting Person disclaims beneficial ownership of all securities held by the SLAT, and this report should not be deemed an admission that the Reporting Person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose, except to the extent of the Reporting Person's pecuniary interest therein, if any. Row 2 · 2026-06-30 · Tax withholding · Disposed 5,024 · Balance 12,314 F1: Held by a Spousal Lifetime Access Trust (the "SLAT"). The Reporting Person's spouse and children are trustees of the SLAT. The Reporting Person disclaims beneficial ownership of all securities held by the SLAT, and this report should not be deemed an admission that the Reporting Person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose, except to the extent of the Reporting Person's pecuniary interest therein, if any.
Stock option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $1.88 · Expires 2026-07-28	IndirectBy SLAT	0	Reported balance After 2026-06-30 transaction · row 4 Instrument identity requires review; Table II rows are not merged. 1 source row Row 4 · 2026-06-30 · Exercise / conversion · Disposed 12,000 · Balance 0 F2: On June 30, 2026, the Reporting Person effected a net exercise of 12,000 stock options with an exercise price of $1.88 per share. Pursuant to the terms of the exercise, 5,024 shares otherwise issuable upon exercise were withheld by the issuer at a value of $4.49 per share to satisfy the aggregate exercise price, resulting in the issuance of 6,976 net shares to the Reporting Person. F1: Held by a Spousal Lifetime Access Trust (the "SLAT"). The Reporting Person's spouse and children are trustees of the SLAT. The Reporting Person disclaims beneficial ownership of all securities held by the SLAT, and this report should not be deemed an admission that the Reporting Person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose, except to the extent of the Reporting Person's pecuniary interest therein, if any.
Common StockSEC Table I · non-derivative	Direct	37,563	Reported balance Holding disclosure · report date 2026-06-30 · row 3 Holding and transaction disclosures are not merged. 1 source row Row 3 · Balance 37,563

Filing footnotes · ownership attribution and instrument terms

F1: Held by a Spousal Lifetime Access Trust (the "SLAT"). The Reporting Person's spouse and children are trustees of the SLAT. The Reporting Person disclaims beneficial ownership of all securities held by the SLAT, and this report should not be deemed an admission that the Reporting Person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose, except to the extent of the Reporting Person's pecuniary interest therein, if any.

F2: On June 30, 2026, the Reporting Person effected a net exercise of 12,000 stock options with an exercise price of $1.88 per share. Pursuant to the terms of the exercise, 5,024 shares otherwise issuable upon exercise were withheld by the issuer at a value of $4.49 per share to satisfy the aggregate exercise price, resulting in the issuance of 6,976 net shares to the Reporting Person.

COMTECH TELECOMMUNICATIONS CORP /DE/

Report date March 24, 2026 · Filed March 26, 2026

Security / award	Ownership account	Disclosed shares / units	Disclosure context
Restricted Stock UnitsSEC Table II · derivative / convertible security	Direct	103,974	Reported balance After 2026-03-24 transaction · row 1 Instrument identity requires review; Table II rows are not merged. 1 source row Row 1 · 2026-03-24 · Grant · Acquired 36,620 · Balance 103,974 F1: Restricted stock units were granted under the Company's 2023 Equity and Incentive Plan, and represent the right to receive one share of common stock of Comtech Telecommunications Corp. upon vesting of the unit. F2: The award will generally vest in full on the earlier of (i) the one-year anniversary of the Grant Date; or (ii) the date of the Company's next annual meeting of stockholders following the Grant Date, provided that such meeting occurs at least fifty (50) weeks after the Company's immediately preceding year's annual meeting of stockholders, in each case, subject to continued service through such vesting date.

Filing footnotes · ownership attribution and instrument terms

F1: Restricted stock units were granted under the Company's 2023 Equity and Incentive Plan, and represent the right to receive one share of common stock of Comtech Telecommunications Corp. upon vesting of the unit.

F2: The award will generally vest in full on the earlier of (i) the one-year anniversary of the Grant Date; or (ii) the date of the Company's next annual meeting of stockholders following the Grant Date, provided that such meeting occurs at least fifty (50) weeks after the Company's immediately preceding year's annual meeting of stockholders, in each case, subject to continued service through such vesting date.

CVD EQUIPMENT CORP

Report date August 08, 2025 · Filed August 12, 2025

Security / award	Ownership account	Disclosed shares / units	Disclosure context
Common StockSEC Table I · non-derivative	Direct	79,146	Reported balance After 2025-08-08 transaction · row 1 1 source row Row 1 · 2025-08-08 · Grant · Acquired 11,100 · Balance 79,146 F1: Automatic grant issued on the date of the Company's 2025 Annual Meeting of Shareholders pursuant to the Company's previously disclosed Director Compensation Plan. Such grant consists of Common Stock issued pursuant to the Company's 2022 Share Incentive Plan and will vest at each quarter (September 30, 2025, December 31, 2025, March 31, 2026 and June 30, 2026) provided that the recipient is still serving as a Director on the respective vesting dates.

Filing footnotes · ownership attribution and instrument terms

F1: Automatic grant issued on the date of the Company's 2025 Annual Meeting of Shareholders pursuant to the Company's previously disclosed Director Compensation Plan. Such grant consists of Common Stock issued pursuant to the Company's 2022 Share Incentive Plan and will vest at each quarter (September 30, 2025, December 31, 2025, March 31, 2026 and June 30, 2026) provided that the recipient is still serving as a Director on the respective vesting dates.

Past disclosures · reporting ended (1)

No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.

NorthStar/RXR New York Metro Real Estate, Inc.

Report date October 22, 2018 · Filed October 22, 2018

Section 16 reporting ended · disclosed 2018-10-22. Current position is not established by this disclosure.

Security / award	Ownership account	Disclosed shares / units	Disclosure context
Common StockSEC Table I · non-derivative	Direct	0	Reported balance After 2018-10-22 transaction · row 1 1 source row Row 1 · 2018-10-22 · Disposition to issuer · Disposed 11,163 · Balance 0 F1: Pursuant to that certain Agreement and Plan of Merger (the "Merger Agreement"), dated as of August 20, 2018, by and between NorthStar/RXR New York Metro Real Estate, Inc. (the "Company"), CNI NS/RXR Advisors, LLC, the Company's advisor (the "Advisor"), CNI NS/RXR Advisors Merger Subsidiary, LLC, a wholly-owned subsidiary of the Advisor (the "Merger Sub"), and Colony Capital Investment Holdco, LLC, an affiliate of the Advisor, the Company merged with and into Merger Sub, with Merger Sub surviving, and each share of the Company's common stock, par value $0.01 per share (the "Common Stock") was converted into the right to receive $9.1877. Includes 938 shares of restricted Common Stock granted pursuant to the Company's Independent Director Compensation Plan (the "Plan"), the vesting of which was accelerated in connection with the Merger in accordance with the Plan and the Merger Agreement.

Filing footnotes · ownership attribution and instrument terms

F1: Pursuant to that certain Agreement and Plan of Merger (the "Merger Agreement"), dated as of August 20, 2018, by and between NorthStar/RXR New York Metro Real Estate, Inc. (the "Company"), CNI NS/RXR Advisors, LLC, the Company's advisor (the "Advisor"), CNI NS/RXR Advisors Merger Subsidiary, LLC, a wholly-owned subsidiary of the Advisor (the "Merger Sub"), and Colony Capital Investment Holdco, LLC, an affiliate of the Advisor, the Company merged with and into Merger Sub, with Merger Sub surviving, and each share of the Company's common stock, par value $0.01 per share (the "Common Stock") was converted into the right to receive $9.1877. Includes 938 shares of restricted Common Stock granted pursuant to the Company's Independent Director Compensation Plan (the "Plan"), the vesting of which was accelerated in connection with the Merger in accordance with the Plan and the Merger Agreement.

Transaction history

JSON API

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction date	Company	Activity / security	Shares / units	Reported price	Reported value	Details
June 30, 2026 Filed Jul 2, 2026 21:00 UTC	Apyx Medical Corp APYX · Entity 6609	Exercise / conversionStock option (right to buy) · Derivative	12,000	$0.00 Strike: $1.88	$0.00	Disclosure SEC source: 0001493152-26-031944 · ownership.xml · derivative · entry 4 Waldman Lawrence · CIK 0001516592 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · By SLAT Disclosed balance after: 0 Underlying: Common Stock · 12,000 shares Expires 2026-07-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: On June 30, 2026, the Reporting Person effected a net exercise of 12,000 stock options with an exercise price of $1.88 per share. Pursuant to the terms of the exercise, 5,024 shares otherwise issuable upon exercise were withheld by the issuer at a value of $4.49 per share to satisfy the aggregate exercise price, resulting in the issuance of 6,976 net shares to the Reporting Person. F1 · ownership.nature: Held by a Spousal Lifetime Access Trust (the "SLAT"). The Reporting Person's spouse and children are trustees of the SLAT. The Reporting Person disclaims beneficial ownership of all securities held by the SLAT, and this report should not be deemed an admission that the Reporting Person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose, except to the extent of the Reporting Person's pecuniary interest therein, if any. Read SEC document
June 30, 2026 Filed Jul 2, 2026 21:00 UTC	Apyx Medical Corp APYX · Entity 6609	Tax withholdingCommon Stock	5,024	$4.49	$22,557.76	Disclosure SEC source: 0001493152-26-031944 · ownership.xml · nonDerivative · entry 2 Waldman Lawrence · CIK 0001516592 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · By SLAT Disclosed balance after: 12,314 F1 · ownership.nature: Held by a Spousal Lifetime Access Trust (the "SLAT"). The Reporting Person's spouse and children are trustees of the SLAT. The Reporting Person disclaims beneficial ownership of all securities held by the SLAT, and this report should not be deemed an admission that the Reporting Person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose, except to the extent of the Reporting Person's pecuniary interest therein, if any. Read SEC document
June 30, 2026 Filed Jul 2, 2026 21:00 UTC	Apyx Medical Corp APYX · Entity 6609	Exercise / conversionCommon Stock	12,000	$1.88	$22,560.00	Disclosure SEC source: 0001493152-26-031944 · ownership.xml · nonDerivative · entry 1 Waldman Lawrence · CIK 0001516592 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · By SLAT Disclosed balance after: 17,338 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · ownership.nature: Held by a Spousal Lifetime Access Trust (the "SLAT"). The Reporting Person's spouse and children are trustees of the SLAT. The Reporting Person disclaims beneficial ownership of all securities held by the SLAT, and this report should not be deemed an admission that the Reporting Person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose, except to the extent of the Reporting Person's pecuniary interest therein, if any. Read SEC document
June 11, 2026 Filed Jun 15, 2026 23:00 UTC	Apyx Medical Corp APYX · Entity 6609	GrantStock Option (Option to Buy) · Derivative	50,000	$0.00 Strike: $4.65	$0.00	Disclosure SEC source: 0001493152-26-028767 · ownership.xml · derivative · entry 1 Waldman Lawrence · CIK 0001516592 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 50,000 Underlying: Common Stock · 50,000 shares Expires 2036-06-11 F1 · derivative.exercise_date: Reporting person was granted a stock option which shall vest ratably over a twelve (12) month period and shall become fully vested and fully exercisable on the first anniversary of the date of grant. Read SEC document
March 24, 2026 Filed Mar 26, 2026 20:58 UTC	COMTECH TELECOMMUNICATIONS CORP /DE/ CMTL · Entity 7226	GrantRestricted Stock Units · Derivative	36,620	$0.00	$0.00	Disclosure SEC source: 0001516592-26-000004 · wk-form4_1774558690.xml · derivative · entry 1 Waldman Lawrence · CIK 0001516592 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 103,974 Underlying: Common Stock Par Value $.10 Per Share · 36,620 shares Expires not disclosed F1 · derivative.exercise_price: Restricted stock units were granted under the Company's 2023 Equity and Incentive Plan, and represent the right to receive one share of common stock of Comtech Telecommunications Corp. upon vesting of the unit. F2 · derivative.exercise_date: The award will generally vest in full on the earlier of (i) the one-year anniversary of the Grant Date; or (ii) the date of the Company's next annual meeting of stockholders following the Grant Date, provided that such meeting occurs at least fifty (50) weeks after the Company's immediately preceding year's annual meeting of stockholders, in each case, subject to continued service through such vesting date. F2 · derivative.expiration_date: The award will generally vest in full on the earlier of (i) the one-year anniversary of the Grant Date; or (ii) the date of the Company's next annual meeting of stockholders following the Grant Date, provided that such meeting occurs at least fifty (50) weeks after the Company's immediately preceding year's annual meeting of stockholders, in each case, subject to continued service through such vesting date. Read SEC document
August 08, 2025 Filed Aug 12, 2025 20:00 UTC	CVD EQUIPMENT CORP CVV · Entity 7247	GrantCommon Stock	11,100	$0.00	$0.00	Disclosure SEC source: 0001641172-25-023176 · ownership.xml · nonDerivative · entry 1 Waldman Lawrence · CIK 0001516592 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 79,146 F1 · shares: Automatic grant issued on the date of the Company's 2025 Annual Meeting of Shareholders pursuant to the Company's previously disclosed Director Compensation Plan. Such grant consists of Common Stock issued pursuant to the Company's 2022 Share Incentive Plan and will vest at each quarter (September 30, 2025, December 31, 2025, March 31, 2026 and June 30, 2026) provided that the recipient is still serving as a Director on the respective vesting dates. Read SEC document
May 15, 2025 Filed May 19, 2025 20:31 UTC	Apyx Medical Corp APYX · Entity 6609	GrantStock Option (Option to Buy) · Derivative	30,000	$0.00 Strike: $1.48	$0.00	Disclosure SEC source: 0001641172-25-011478 · ownership.xml · derivative · entry 1 Waldman Lawrence · CIK 0001516592 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 30,000 Underlying: Common Stock · 30,000 shares Expires 2035-05-15 F1 · derivative.exercise_date: Reporting person was granted a stock option which shall vest ratably over a twelve (12) month period and shall become fully vested and fully exercisable on the first anniversary of the date of grant. Read SEC document
January 15, 2025 Filed Jan 17, 2025 21:06 UTC	Apyx Medical Corp APYX · Entity 6609	GrantStock Option (Option to Buy) · Derivative	50,000	$0.00 Strike: $1.42	$0.00	Disclosure SEC source: 0001493152-25-002768 · ownership.xml · derivative · entry 1 Waldman Lawrence · CIK 0001516592 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 50,000 Underlying: Common Stock · 50,000 shares Expires 2035-01-15 F1 · derivative.exercise_date: Issued pursuant to the Issuer's Director Compensation Program, as amended, which provides for the issuance of a stock option to non-employee directors with an exercise price equal to the closing price of the Issuer's common stock on its principal exchange on the second trading day following the Issuer's release of its preliminary 2024 revenue. The option vests ratably over a 12-month period and becomes fully vested and exercisable on the first anniversary of the date of grant. Read SEC document
September 30, 2024 Filed Oct 2, 2024 22:34 UTC	COMTECH TELECOMMUNICATIONS CORP /DE/ CMTL · Entity 7226	GrantRestricted Stock Units · Derivative	27,028	$0.00	$0.00	Disclosure SEC source: 0001516592-24-000005 · wk-form4_1727908444.xml · derivative · entry 1 Waldman Lawrence · CIK 0001516592 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 67,354 Underlying: Common Stock Par Value $.10 Per Share · 27,028 shares Expires not disclosed F1 · derivative.exercise_price: Restricted stock units were granted under the Company's 2023 Equity and Incentive Plan, and represent the right to receive one share of common stock of Comtech Telecommunications Corp. upon vesting of the unit. F2 · derivative.exercise_date: The restricted stock units will cliff vest on the one year anniversary of the grant, assuming continued service as a director. Shares of common stock corresponding to vested units will be delivered to the Reporting Person within 60 days of termination of directorship. F2 · derivative.expiration_date: The restricted stock units will cliff vest on the one year anniversary of the grant, assuming continued service as a director. Shares of common stock corresponding to vested units will be delivered to the Reporting Person within 60 days of termination of directorship. Read SEC document
August 09, 2024 Filed Aug 12, 2024 15:43 UTC	CVD EQUIPMENT CORP CVV · Entity 7247	GrantCommon Stock	11,300	$0.00	$0.00	Disclosure SEC source: 0000766792-24-000005 · primary_doc.xml · nonDerivative · entry 1 Waldman Lawrence · CIK 0001516592 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 68,046 F1 · shares: Automatic grant issued on the date of the Company's Annual Meeting of Shareholders pursuant to the Company's previously disclosed Director Compensation Plan. Such grant consists of Common Stock issued pursuant to the Company's 2022 Share Incentive Plan and will vest at each quarter (September 30, 2024, December 31, 2024, March 31, 2025 and June 30, 2025) provided that the recipient is still serving as a Director on the respective vesting dates. Read SEC document
August 08, 2024 Filed Aug 12, 2024 20:50 UTC	Apyx Medical Corp APYX · Entity 6609	GrantStock Option (Option to Buy) · Derivative	17,000	$0.00 Strike: $1.02	$0.00	Disclosure SEC source: 0001493152-24-031319 · ownership.xml · derivative · entry 1 Waldman Lawrence · CIK 0001516592 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 17,000 Underlying: Common Stock · 17,000 shares Expires 2034-08-08 F1 · derivative.exercise_date: Issued pursuant to the Issuer's Director Compensation Program as set forth in the Issuer's definitive proxy statement filed with the U.S. Securities and Exchange Commission on June 25, 2024, which provides for the issuance of a stock option to non-employee directors on the date of the Issuer's Annual Meeting of Stockholders. The option vests ratably over a 12-month period and becomes fully vested and exercisable on the first anniversary of the date of grant. Read SEC document
August 11, 2023 Filed Aug 16, 2023 00:15 UTC	COMTECH TELECOMMUNICATIONS CORP /DE/ CMTL · Entity 7226	GrantRestricted Stock Units · Derivative	13,904	$0.00	$0.00	Disclosure SEC source: 0001062993-23-016572 · form4.xml · derivative · entry 1 Waldman Lawrence · CIK 0001516592 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 40,326 Underlying: Common Stock Par Value $.10 Per Share · 13,904 shares Expires not disclosed F1 · derivative.exercise_price: Restricted stock units were granted under the Company's 2000 Stock Incentive Plan, and represent the right to receive one share of common stock of Comtech Telecommunications Corp. upon vesting of the unit. F2 · derivative.exercise_date: The restricted stock units will cliff vest on the one year anniversary of the grant, assuming continued service as a director. Shares of common stock corresponding to vested units will be delivered to the Reporting Person within 30 days of termination of directorship. F2 · derivative.expiration_date: The restricted stock units will cliff vest on the one year anniversary of the grant, assuming continued service as a director. Shares of common stock corresponding to vested units will be delivered to the Reporting Person within 30 days of termination of directorship. Read SEC document
August 10, 2023 Filed Aug 15, 2023 16:27 UTC	Apyx Medical Corp APYX · Entity 6609	GrantStock Option (Option to Buy) · Derivative	17,000	$0.00 Strike: $4.25	$0.00	Disclosure SEC source: 0001493152-23-028921 · ownership.xml · derivative · entry 1 Waldman Lawrence · CIK 0001516592 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 17,000 Underlying: Common Stock · 17,000 shares Expires 2033-08-10 F1 · derivative.exercise_date: Reporting person was granted a stock option which shall vest ratably over a twelve (12) month period and shall become fully vested and fully exercisable on the first anniversary of the date of grant. Read SEC document
July 13, 2023 Filed Jul 17, 2023 17:28 UTC	CVD EQUIPMENT CORP CVV · Entity 7247	GrantCommon Stock	5,831	$0.00	$0.00	Disclosure SEC source: 0000766792-23-000007 · primary_doc.xml · nonDerivative · entry 2 Waldman Lawrence · CIK 0001516592 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 56,746 F2 · shares: Common stock issued pursuant to the Company's 2022 Share Incentive Plan, and will vest 25% at each quarter end, September 30, 2023, December 31, 2023, March 31, 2024 and June 30, 2024, provided that such individual is still serving as a Director as of the vesting dates. Read SEC document
July 13, 2023 Filed Jul 17, 2023 17:28 UTC	CVD EQUIPMENT CORP CVV · Entity 7247	GrantCommon Stock	2,915	$0.00	$0.00	Disclosure SEC source: 0000766792-23-000007 · primary_doc.xml · nonDerivative · entry 1 Waldman Lawrence · CIK 0001516592 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 50,915 F1 · shares: Common stock issued pursuant to the Company's 2022 Share Incentive Plan and fully vested on the date of issuance. Read SEC document
July 12, 2023 Filed Jul 19, 2023 16:00 UTC	Apyx Medical Corp APYX · Entity 6609	Exercise / conversionStock Option (Option to Buy) · Derivative	12,000	$0.00 Strike: $2.97	$0.00	Disclosure SEC source: 0001493152-23-024899 · ownership.xml · derivative · entry 3 Waldman Lawrence · CIK 0001516592 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · By SLAT Disclosed balance after: 0 Underlying: Common Stock · 12,000 shares Expires 2023-07-16 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document
July 12, 2023 Filed Jul 19, 2023 16:00 UTC	Apyx Medical Corp APYX · Entity 6609	Exercise / conversionCommon Stock	5,338	$2.97	$15,853.86	Disclosure SEC source: 0001493152-23-024899 · ownership.xml · nonDerivative · entry 1 Waldman Lawrence · CIK 0001516592 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · By SLAT Disclosed balance after: 5,338 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Represents a "net exercise" of outstanding stock options. The Reporting Person received 5,338 shares of common stock on net exercise of an option to purchase 12,000 shares of common stock. F2 · balance_after: The Reporting Person transferred this option to a Spousal Lifetime Access Trust (the "SLAT"). The Reporting Person's spouse and children are trustees of the SLAT. F3 · ownership.nature: The Reporting Person disclaims beneficial ownership of all securities held by the SLAT, and this report should not be deemed an admission that the Reporting Person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose, except to the extent of the Reporting Person's pecuniary interest therein, if any. Read SEC document
August 17, 2022 Filed Aug 18, 2022 18:36 UTC	CVD EQUIPMENT CORP cvv · Entity 7247	GrantCommon Stock	8,000	$5.02	$40,160.00	Disclosure SEC source: 0001516592-22-000001 · primary_doc.xml · nonDerivative · entry 1 Waldman Lawrence · CIK 0001516592 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 48,000 F1 · shares: Common Stock issued pursuant to the Corporations 2016 share incentive plan, vest 4,000 shares on Aug. 17, 2022 and December 31, 2022, provided that such individual is still serving as a Director as of the vesting date. Read SEC document
August 12, 2022 Filed Aug 15, 2022 22:59 UTC	COMTECH TELECOMMUNICATIONS CORP /DE/ CMTL · Entity 7226	GrantRestricted Stock Units · Derivative	10,718	$0.00	$0.00	Disclosure SEC source: 0001062993-22-018055 · form4.xml · derivative · entry 1 Waldman Lawrence · CIK 0001516592 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,422 Underlying: Common Stock Par Value $.10 Per Share · 10,718 shares Expires not disclosed F1 · derivative.exercise_price: Restricted stock units were granted under the Company's 2000 Stock Incentive Plan, and represent the right to receive one share of common stock of Comtech Telecommunications Corp. upon vesting of the unit. F2 · derivative.exercise_date: The restricted stock units will cliff vest on the one year anniversary of the grant, assuming continued service as a director. Shares of common stock corresponding to vested units will be delivered to the Reporting Person within 30 days of termination of directorship. F2 · derivative.expiration_date: The restricted stock units will cliff vest on the one year anniversary of the grant, assuming continued service as a director. Shares of common stock corresponding to vested units will be delivered to the Reporting Person within 30 days of termination of directorship. Read SEC document
August 11, 2022 Filed Aug 17, 2022 20:30 UTC	Apyx Medical Corp APYX · Entity 6609	GrantStock Option (Option to Buy) · Derivative	17,000	$0.00 Strike: $10.28	$0.00	Disclosure SEC source: 0000719135-22-000082 · wf-form4_166076815906396.xml · derivative · entry 1 Waldman Lawrence · CIK 0001516592 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,000 Underlying: Common Stock · 17,000 shares Expires 2032-08-11 F1 · derivative.exercise_date: Reporting person was granted a stock option which shall vest ratably over a twelve (12) month period and shall become fully vested and fully exercisable on the first anniversary of the date of grant. Read SEC document
July 11, 2022 Filed Jul 11, 2022 20:54 UTC	Apyx Medical Corp APYX · Entity 6609	Exercise / conversionStock Option (Option to Buy) · Derivative	24,000	$0.00 Strike: $2.54	$0.00	Disclosure SEC source: 0000719135-22-000053 · wf-form4_165757287331904.xml · derivative · entry 2 Waldman Lawrence · CIK 0001516592 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 24,000 shares Expires 2022-07-12 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: Reporting Person was granted a stock option that vested and became exercisable over 3 years at a rate of 33.33% of the option on the anniversary date of each succeeding year. Read SEC document
July 11, 2022 Filed Jul 11, 2022 20:54 UTC	Apyx Medical Corp APYX · Entity 6609	Exercise / conversionCommon Stock	24,000	$2.54	$60,960.00	Disclosure SEC source: 0000719135-22-000053 · wf-form4_165757287331904.xml · nonDerivative · entry 1 Waldman Lawrence · CIK 0001516592 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,563 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document
May 19, 2022 Filed May 23, 2022 14:26 UTC	Apyx Medical Corp APYX · Entity 6609	Exercise / conversionStock Option (Option to Buy) · Derivative	8,000	$0.00 Strike: $2.79	$0.00	Disclosure SEC source: 0000719135-22-000037 · wf-form4_165331595436282.xml · derivative · entry 2 Waldman Lawrence · CIK 0001516592 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 8,000 shares Expires 2022-05-21 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document
May 19, 2022 Filed May 23, 2022 14:26 UTC	Apyx Medical Corp APYX · Entity 6609	Exercise / conversionCommon Stock	8,000	$2.79	$22,320.00	Disclosure SEC source: 0000719135-22-000037 · wf-form4_165331595436282.xml · nonDerivative · entry 1 Waldman Lawrence · CIK 0001516592 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,563 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document
August 10, 2021 Filed Aug 12, 2021 21:37 UTC	COMTECH TELECOMMUNICATIONS CORP /DE/ CMTL · Entity 7226	GrantCommon Stock Par Value $0.10 Per Share	4,476	$0.00	$0.00	Disclosure SEC source: 0000023197-21-000054 · edgar.xml · nonDerivative · entry 1 Waldman Lawrence · CIK 0001516592 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,435 F1 · security: Restricted stock awards were granted under the Company's 2000 Stock Incentive Plan, and represent the right to receive one share of common stock of Comtech Telecommunications Corp. upon vesting. F2 · security: Generally, the restricted stock awards will vest in installments over a five year period, at a rate of 20% on the first through fifth anniversaries of grant, assuming continued service as a director. Shares of common stock corresponding to vested awards will be delivered to the Reporting Person within 30 days of vesting. Read SEC document
August 06, 2021 Filed Aug 11, 2021 15:55 UTC	Apyx Medical Corp APYX · Entity 6609	GrantStock Option (Option to Buy) · Derivative	17,000	$0.00 Strike: $9.42	$0.00	Disclosure SEC source: 0000719135-21-000047 · wf-form4_162869727728129.xml · derivative · entry 1 Waldman Lawrence · CIK 0001516592 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,000 Underlying: Common Stock · 17,000 shares Expires 2031-08-06 F1 · derivative.exercise_date: Reporting person was granted a stock option which shall vest ratably over a twelve (12) month period and shall become fully vested and fully exercisable on the first anniversary of the date of grant. Read SEC document
March 08, 2021 Filed Mar 8, 2021 20:09 UTC	Apyx Medical Corp APYX · Entity 6609	OtherStock Option (Option to Buy) · Derivative	7,500	$2.81 Strike: $2.81	$21,075.00	Disclosure SEC source: 0000719135-21-000021 · wf-form4_161523415612140.xml · derivative · entry 2 Waldman Lawrence · CIK 0001516592 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 7,500 shares Expires 2021-03-18 F1 · kind: The transactions reported reflect the net exercise of stock options. Read SEC document
March 08, 2021 Filed Mar 8, 2021 20:09 UTC	Apyx Medical Corp APYX · Entity 6609	Exercise / conversionCommon Stock	5,563	$2.81	$15,632.03	Disclosure SEC source: 0000719135-21-000021 · wf-form4_161523415612140.xml · nonDerivative · entry 1 Waldman Lawrence · CIK 0001516592 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,563 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported reflect the net exercise of stock options. Read SEC document
January 15, 2021 Filed Nov 24, 2021 18:27 UTC	CVD EQUIPMENT CORP cvv · Entity 7247	GrantCommon Stock	9,600	$4.70	$45,120.00	Disclosure SEC source: 0001516592-21-000001 · primary_doc.xml · nonDerivative · entry 1 Waldman Lawrence · CIK 0001516592 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,000 F1 · shares: Common Stock issued pursuant to the Corporations 2016 share Incentive Plan, vest as to 2,400 shares on each March 31, 2021, June 30, 2021, September 30, 2021 and December 31, 2021, or as the date of the 2021 annual meeting of shareholders but in no event earlier than November 15, 2021 provided that such individual is still serving as a Director as of the vesting date. Read SEC document
August 06, 2020 Filed Feb 12, 2021 19:39 UTC	Apyx Medical Corp APYX · Entity 6609	GrantStock Option (Option to Buy) · Derivative	17,000	$4.98 Strike: $4.98	$84,660.00	Disclosure SEC source: 0000719135-21-000017 · wf-form5_161315874265844.xml · derivative · entry 1 Waldman Lawrence · CIK 0001516592 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,000 Underlying: Common Stock · 17,000 shares Expires 2030-08-06 F1 · derivative.exercise_date: Reporting person was granted a stock option which shall vest ratably over a twelve (12) month period and shall become fully vested and fully exercisable on the first anniversary of the date of grant. Read SEC document
August 04, 2020 Filed Aug 6, 2020 20:25 UTC	COMTECH TELECOMMUNICATIONS CORP /DE/ CMTL · Entity 7226	GrantCommon Stock Par Value $0.10 Per Share	7,195	$0.00	$0.00	Disclosure SEC source: 0000023197-20-000081 · edgar.xml · nonDerivative · entry 1 Waldman Lawrence · CIK 0001516592 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,959 F1 · security: Restricted stock awards were granted under the Company's 2000 Stock Incentive Plan, and represent the right to receive one share of common stock of Comtech Telecommunications Corp. upon vesting. F2 · security: Generally, the restricted stock awards will vest in installments over a five year period, at a rate of 20% on the first through fifth anniversaries of grant, assuming continued service as a director. Shares of common stock corresponding to vested awards will be delivered to the reporting person within 30 days of vesting. Read SEC document
May 28, 2020 Filed May 29, 2020 22:03 UTC	COMTECH TELECOMMUNICATIONS CORP /DE/ CMTL · Entity 7226	GrantStock Option Right to Buy · Derivative	3,000	$0.00 Strike: $17.88	$0.00	Disclosure SEC source: 0000023197-20-000042 · edgar.xml · derivative · entry 5 Waldman Lawrence · CIK 0001516592 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,890 Underlying: Common stock par value $.10 per share · 3,000 shares Expires 2030-05-28 F1 · security: Option was granted pursuant to the Company's 2000 Stock Incentive Plan. Read SEC document
May 28, 2020 Filed May 29, 2020 22:03 UTC	COMTECH TELECOMMUNICATIONS CORP /DE/ CMTL · Entity 7226	GrantStock Option Right to Buy · Derivative	3,000	$0.00 Strike: $17.88	$0.00	Disclosure SEC source: 0000023197-20-000042 · edgar.xml · derivative · entry 4 Waldman Lawrence · CIK 0001516592 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,890 Underlying: Common stock par value $.10 per share · 3,000 shares Expires 2030-05-28 F1 · security: Option was granted pursuant to the Company's 2000 Stock Incentive Plan. Read SEC document
May 28, 2020 Filed May 29, 2020 22:03 UTC	COMTECH TELECOMMUNICATIONS CORP /DE/ CMTL · Entity 7226	GrantStock Option Right to Buy · Derivative	3,000	$0.00 Strike: $17.88	$0.00	Disclosure SEC source: 0000023197-20-000042 · edgar.xml · derivative · entry 3 Waldman Lawrence · CIK 0001516592 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,890 Underlying: Common stock par value $.10 per share · 3,000 shares Expires 2030-05-28 F1 · security: Option was granted pursuant to the Company's 2000 Stock Incentive Plan. Read SEC document
May 28, 2020 Filed May 29, 2020 22:03 UTC	COMTECH TELECOMMUNICATIONS CORP /DE/ CMTL · Entity 7226	GrantStock Option Right to Buy · Derivative	3,000	$0.00 Strike: $17.88	$0.00	Disclosure SEC source: 0000023197-20-000042 · edgar.xml · derivative · entry 2 Waldman Lawrence · CIK 0001516592 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,890 Underlying: Common stock par value $.10 per share · 3,000 shares Expires 2030-05-28 F1 · security: Option was granted pursuant to the Company's 2000 Stock Incentive Plan. Read SEC document
May 28, 2020 Filed May 29, 2020 22:03 UTC	COMTECH TELECOMMUNICATIONS CORP /DE/ CMTL · Entity 7226	GrantStock Option Right to Buy · Derivative	3,000	$0.00 Strike: $17.88	$0.00	Disclosure SEC source: 0000023197-20-000042 · edgar.xml · derivative · entry 1 Waldman Lawrence · CIK 0001516592 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,890 Underlying: Common stock par value $.10 per share · 3,000 shares Expires 2030-05-28 F1 · security: Option was granted pursuant to the Company's 2000 Stock Incentive Plan. Read SEC document
January 15, 2020 Filed Jan 16, 2020 19:17 UTC	CVD EQUIPMENT CORP cvv · Entity 7247	GrantCommon Stock	12,200	$3.74	$45,628.00	Disclosure SEC source: 0001516592-20-000001 · primary_doc.xml · nonDerivative · entry 1 Waldman Lawrence · CIK 0001516592 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,400 F1 · shares: Common Stock issued pursuant to the Corporations 2016 Share Incentive Plan, vest as to 3,050 shares on each of March 31, 2020, June 30, 2020, September 30, 2020 and December 31, 2020 or as of the date of the 2020 annual meeting of shareholders but in no event earlier than November 15, 2020, provided that such individual is still serving as a Director as of the vesting date. Read SEC document
August 09, 2019 Filed Aug 13, 2019 20:51 UTC	COMTECH TELECOMMUNICATIONS CORP /DE/ CMTL · Entity 7226	GrantCommon Stock Par Value $0.10 Per Share	4,302	$0.00	$0.00	Disclosure SEC source: 0000023197-19-000057 · edgar.xml · nonDerivative · entry 1 Waldman Lawrence · CIK 0001516592 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,764 F1 · security: Restricted stock awards were granted under the Company's 2000 Stock Incentive Plan, and represent the right to receive one share of common stock of Comtech Telecommunications Corp. upon vesting. F2 · security: Generally, the restricted stock awards will vest in installments over a five year period, at a rate of 20% on the first through fifth anniversaries of grant, assuming continued service as a director. Shares of common stock corresponding to vested awards will be delivered to the reporting person within 30 days of vesting. Read SEC document
August 01, 2019 Filed Aug 5, 2019 20:38 UTC	Apyx Medical Corp APYX · Entity 6609	GrantStock Option (Option to Buy) · Derivative	17,000	$0.00 Strike: $7.28	$0.00	Disclosure SEC source: 0000719135-19-000031 · wf-form4_156503746803331.xml · derivative · entry 1 Waldman Lawrence · CIK 0001516592 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,000 Underlying: Common Stock · 17,000 shares Expires 2029-08-01 F1 · derivative.exercise_date: Reporting person was granted a stock option in accordance with director compensation plan which shall vest ratably over a twelve (12) month period and shall become fully vested and fully exercisable on the first anniversary of the date of grant. Read SEC document
January 15, 2019 Filed Feb 26, 2019 16:04 UTC	CVD EQUIPMENT CORP CVV · Entity 7247	GrantOption to purchase common stock · Derivative	15,000	$0.00 Strike: $5.00	$0.00	Disclosure SEC source: 0001079810-19-000004 · primary_doc.xml · derivative · entry 2 Waldman Lawrence · CIK 0001516592 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,000 Underlying: Common Stock · 15,000 shares Expires 2030-01-15 Read SEC document
January 15, 2019 Filed Feb 26, 2019 16:04 UTC	CVD EQUIPMENT CORP CVV · Entity 7247	GrantCommon Stock	11,400	$3.99	$45,486.00	Disclosure SEC source: 0001079810-19-000004 · primary_doc.xml · nonDerivative · entry 1 Waldman Lawrence · CIK 0001516592 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,200 F1 · shares: Common stock issued pursuant to the Corporation's 2016 Share Incentive Plan, vests as to 2,850 shares on each of March 31, 2019, June 30, 2019, September 30, 2019 and December 31, 2019 or as of the date of the 2019 annual meeting of shareholders but in no event earlier than November 15, 2019, provided that such individual is still serving as a Director as of the vesting date. Read SEC document
October 22, 2018 Filed Oct 22, 2018 21:34 UTC	NorthStar/RXR New York Metro Real Estate, Inc. NONE · Entity 162864	Disposition to issuerCommon Stock	11,163	$9.19	$102,562.30	Disclosure SEC source: 0001415889-18-001535 · form4-10222018_021025.xml · nonDerivative · entry 1 Waldman Lawrence · CIK 0001516592 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · shares: Pursuant to that certain Agreement and Plan of Merger (the "Merger Agreement"), dated as of August 20, 2018, by and between NorthStar/RXR New York Metro Real Estate, Inc. (the "Company"), CNI NS/RXR Advisors, LLC, the Company's advisor (the "Advisor"), CNI NS/RXR Advisors Merger Subsidiary, LLC, a wholly-owned subsidiary of the Advisor (the "Merger Sub"), and Colony Capital Investment Holdco, LLC, an affiliate of the Advisor, the Company merged with and into Merger Sub, with Merger Sub surviving, and each share of the Company's common stock, par value $0.01 per share (the "Common Stock") was converted into the right to receive $9.1877. Includes 938 shares of restricted Common Stock granted pursuant to the Company's Independent Director Compensation Plan (the "Plan"), the vesting of which was accelerated in connection with the Merger in accordance with the Plan and the Merger Agreement. Read SEC document
August 30, 2018 Filed Sep 10, 2018 15:34 UTC	Apyx Medical Corp BVX · Entity 6609	GrantStock Option (Option to Buy) · Derivative	24,000	$0.00 Strike: $5.30	$0.00	Disclosure SEC source: 0000719135-18-000069 · wf-form4_153659364219494.xml · derivative · entry 1 Waldman Lawrence · CIK 0001516592 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,000 Underlying: Common Stock · 24,000 shares Expires 2028-08-29 F1 · derivative.exercise_price: Reporting person was granted a stock option which shall vest ratably over a twelve (12) month period and shall become fully vested and fully exercisable on the first anniversary of the date of grant. F1 · derivative.exercise_date: Reporting person was granted a stock option which shall vest ratably over a twelve (12) month period and shall become fully vested and fully exercisable on the first anniversary of the date of grant. Read SEC document
August 08, 2018 Filed Aug 10, 2018 22:07 UTC	COMTECH TELECOMMUNICATIONS CORP /DE/ CMTL · Entity 7226	GrantCommon Stock Par Value $0.10 Per Share	3,462	$0.00	$0.00	Disclosure SEC source: 0000023197-18-000043 · edgar.xml · nonDerivative · entry 1 Waldman Lawrence · CIK 0001516592 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,462 F1 · security: Restricted stock awards were granted under the Company's 2000 Stock Incentive Plan, and represent the right to receive one share of common stock of Comtech Telecommunications Corp. upon vesting. F2 · security: Generally, the restricted stock awards will vest in installments over a three year period, at a rate of 25% on the first and second anniversaries of grant and 50% on the third anniversary of grant, assuming continued service as a director. Shares of common stock corresponding to vested awards will be delivered to the reporting person within 30 days of vesting. Read SEC document
January 18, 2018 Filed Jan 23, 2018 14:48 UTC	CVD EQUIPMENT CORP CVV · Entity 7247	Exercise / conversionCommon Stock	2,800	$11.02	$30,856.00	Disclosure SEC source: 0001079810-18-000002 · primary_doc.xml · nonDerivative · entry 1 Waldman Lawrence · CIK 0001516592 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,800 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Common stock issued pursuant to the Corporation's 2016 Share Incentive Plan, vests as to 700 shares on each of March 31, 2018. June 30, 2018, September 30, 2018 and December 31, 2018 or as of the 2018 annual meeting of shareholders but in no event earlier than November 15, 2018, provided that such individual is still serving as a Director as of the vesting date. Read SEC document
September 14, 2017 Filed Sep 27, 2017 13:03 UTC	Apyx Medical Corp BVX · Entity 6609	GrantStock Option (Option to Buy) · Derivative	12,000	$0.00 Strike: $2.85	$0.00	Disclosure SEC source: 0000719135-17-000046 · wf-form4_150651740888909.xml · derivative · entry 1 Waldman Lawrence · CIK 0001516592 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,000 Underlying: Common Stock · 12,000 shares Expires 2027-09-13 F1 · derivative.exercise_price: Reporting person was granted a stock option which shall vest ratably over a twelve (12) month period and shall become fully vested and fully exercisable on the first anniversary of the date of grant. F1 · derivative.exercise_date: Reporting person was granted a stock option which shall vest ratably over a twelve (12) month period and shall become fully vested and fully exercisable on the first anniversary of the date of grant. Read SEC document
August 09, 2017 Filed Aug 11, 2017 21:07 UTC	COMTECH TELECOMMUNICATIONS CORP /DE/ CMTL · Entity 7226	GrantRestricted Stock Units · Derivative	6,579	$0.00	$0.00	Disclosure SEC source: 0000023197-17-000049 · edgar.xml · derivative · entry 1 Waldman Lawrence · CIK 0001516592 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,704 Underlying: Common stock par value $.10 per share · 6,579 shares Expires not disclosed F1 · derivative.exercise_price: This transaction represents the grant of restricted stock units pursuant to the Company's 2000 Stock Incentive Plan, and represent the right to receive one share of common stock of Comtech Telecommunications Corp. upon vesting of the unit. F2 · derivative.exercise_date: Generally, the restricted stock units will vest in installments over a three year period, at a rate of 25% on the first and second anniversaries of grant and 50% on the third anniversary of grant, assuming continued service as a director. Shares of common stock corresponding to vested units will be delivered to the reporting person within 30 days of termination of directorship. F2 · derivative.expiration_date: Generally, the restricted stock units will vest in installments over a three year period, at a rate of 25% on the first and second anniversaries of grant and 50% on the third anniversary of grant, assuming continued service as a director. Shares of common stock corresponding to vested units will be delivered to the reporting person within 30 days of termination of directorship. Read SEC document
January 17, 2017 Filed Jan 18, 2017 22:37 UTC	CVD EQUIPMENT CORP CVV · Entity 7247	GrantCommon Stock	3,100	$9.70	$30,070.00	Disclosure SEC source: 0001079810-17-000003 · primary_doc.xml · nonDerivative · entry 1 Waldman Lawrence · CIK 0001516592 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,000 F1 · shares: Common stock issued pursuant to the Corporation's 2007 Share Incentive Plan, vests as to 775 shares on each of March 31, 2017, June 30, 2017, September 30, 2017 and December 31, 2017 or as of the 2017 annual meeting of shareholders but in no event earlier than November 15, 2017, provided that such individual is still serving as a Director as of the vesting date. Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.